Featured News Defence’s AccuTOX Anti-Cancer ARM-002 Vaccine Exhibits Potent Antigen Presentation April 23, 2024
Biotech Defence’s Successful Submission of an Investigational New Drug (IND) Application for AccuTOX(R) as an Injectable Anticancer Treatment for Solid Tumors November 14, 2023
Biotech Defence Therapeutics Key Platform Patent Accepted Broadly Covering Vaccine Technology November 7, 2023
Featured News Defence’s Delivery of Encapsulated AccuTOX(TM)-Chitosan Nanoparticles Triggers Complete Tumor Regression in Animals with Pre-Established Solid Lymphoma October 17, 2023